Evogene to Present at Cantor Virtual Global Healthcare Conference, September 2021

REHOVOT, Israel, Sept. 14, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational predictive biology company aiming to revolutionize life-science product development acros\s several market segments, announced today that Mr. Ofer Haviv, Evogene's President and CEO, will be interviewed in a "Fireside Chat" at the Cantor Virtual Global Healthcare Conference taking place on September 27-30, 2021. Mr. Haviv's  interview will focus on Evogene's disruptive technologies; its tailor-made engines for product discovery and development and its fields of activity through its main subsidiaries and will take place on Tuesday September 28, 2021, at 10:40 am, EST and will be available through the following webcast link: https://wsw.com/webcast/cantor12/evgn/2086560.

Investors attending the conference who wish to meet with Mr. Haviv, may contact Evogene's Investor Relations team at [email protected] or through the conference's online meeting platform.

About Evogene Ltd.:

Evogene (NASDAQ: EVGN) (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd. For more information, please visit www.evogene.com.

Evogene Investor Contact: Aviva Banczewski / Rivka NeufeldInvestor Relations and Public Relations ManagerE: [email protected] T: +972-8-931-1900

US Investor Relations: Joseph GreenEdison GroupE: [email protected]  T: +1 646-653-7030Laine YonkerEdison GroupE: [email protected]  T: +1 646-653-7035

View original content:https://www.prnewswire.com/news-releases/evogene-to-present-at-cantor-virtual-global-healthcare-conference-september-2021-301376087.html

SOURCE Evogene